|
|
Tissue Engineered Total Disc Replacement in a Large Animal Model |
| RX002274-05 |
SMITH, HARVEY E |
VA |
2023 |
|
|
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis |
| 1R01HL162120-01 |
|
NHLBI |
2022 |
|
|
Contact Pathway Activation on Vascular Devices |
| 2R01HL144113-05 |
|
NHLBI |
2022 |
|
|
Sarcoglycan in Myopathy and Muscle Membrane Stability |
| 5R01HL061322-23 |
|
NHLBI |
2022 |
|
|
Synthetic Mesenchymal Stem Cell Niches for Vascular Therapy |
| 5R01HL119371-09 |
|
NHLBI |
2022 |
|
|
Impaired Mitochondrial Energetics is a Driver of Hemodialysis Access Related Hand Dysfunction |
| 5R01HL148597-04 |
|
NHLBI |
2022 |
|
|
Molecular mechanisms regulating peripheral arterial disease pathobiology in chronic kidney disease |
| 5R01HL149704-03 |
|
NHLBI |
2022 |
|
|
Gut Microbiota and Cerebral Vascular Disease |
| 5R01HL150537-03 |
|
NHLBI |
2022 |
|
|
Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimers and Cardiomyopathy |
| 5R01HL156116-02 |
|
NHLBI |
2022 |
|
|
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells |
| 5R35HL139937-05 |
|
NHLBI |
2022 |